“ME-TOO” DRUGS: GOOD OR BAD?

Introduction

A drug which is structurally unequivocally matching to already great known drugs, with customarily teenager differences. The tenure “me-too” carries a disastrous connotation. However, me-too products might emanate foe as great as expostulate prices down1.

The infancy of a code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new products a courtesy puts out, have been “me-too” drugs, which have been roughly matching to stream treatments nonetheless “no improved than drug already upon a marketplace to yield a same condition.” Around 75 percent of code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new drug authorized by a FDA have been me-too drugs. They can be reduction in effect than stream drugs, nonetheless as prolonged as they’re some-more in effect than a placebo, they can get a regulatory immature light2.

This isn’t startling during all, as someone who functions in a field, nonetheless these supposed “me-too” drugs, which have been reportedly improved than their forebears, is pushing costs. A “me-too” drug is a drug which has a origins in an additional drug. Probably a many critical e.g. of this is Prilosec (“The Purple Pill”) as great as Nexium (“Today’s Purple Pill”). Prilosec’s active partial is omeprazole. Nexium’s active partial is called esomeprazole. The disproportion is which Nexium is a maladroit chronicle of omeprazole. In chemistry, S stands for sinister, which equates to a molecular figure has a maladroit orientation. (D would be right handed.) So this S-omeprazole is a single half of a reduction which comprises a predecessor. By privately picking customarily a S conformation, a drug is done some-more potent. This sounds great, nonetheless a efficiency is customarily marginally improved than Prilosec-, which has a general version, as great as costs about a third reduction than Nexium. Some alternative “me-too” drug are: Claritin (loratidine) as great as Clarinex (desloratidine), Celexa (citalopram) as great as Lexapro (escitalopram)3.

What have been “Me-Too” drugs?

Ever since a appearance of complicated chemotherapy, when drug were detected as great as grown by a routine of screening thousands of molecules for a accumulation of mildew conditions, regulating animal models, there has been a flourishing critique which as great many molecules were grown with matching containing alkali have up as great as a same pharmacological profile, with unequivocally small to heed them from any alternative in conditions of their healing utility. In alternative words, once a primary code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new thing find is done of a code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new pharmacological wake up for a code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new molecule, successive years saw a presentation of a horde of code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new molecules or “me-too” drug from a same containing alkali difficulty as great as possessing a same pharmacological profile.

Such follow-up drug have been termed molecular modifications, molecular roulettes or copycats, a growth of which have been purported to be encouraged by utterly blurb considerations. They have been additionally deemed to engage revoke levels of innovation, compared to a strange molecule. It is critical to investigate in a chronological viewpoint a finish formula of such efforts in opposite healing areas of building code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new molecular entities, as after epoch products, after an primary code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new thing find has been done as great as a technical, healing as great as blurb merits of building such drugs.

Development of “Me-Too” drugs

The success rate in a find of code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new containing alkali entities with essentially code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new containing alkali as great as biological profiles of wake up have been unequivocally low. In fact, even containing alkali entities inside of a same constructional difficulty of an authorized drug have been apropos singular now, compared to a duration of sixties to eighties. In 2001, $ twenty-six billion was outlayed upon building code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new drug as great as a U.S. FDA authorized customarily 9 code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new containing alkali entities. At a same time, dual thirds of a drug authorized from 1989 to 2000 were mutated versions of existent drug or even matching to those, in newer forms as great as formulations4.

Of a 1,035 drug authorized by FDA during 1989 to 2000, customarily 361 or 35% contained code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new active ingredients. Of these, customarily fewer than half were postulated priority examination standing by a FDA. One clarity is which these drug have been somewhat changed versions of existent drugs, with small to suggest in conditions of improved wake up or tolerance, let alone code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new pharmacological profiles. The import is which such drug have been developed, as patents upon top-selling strange drug run out as great as not many in truth code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new medicines have been discovered. The denote which many of these drug do not suggest any vital advantages over existent drug is since by FDA’s rejection to accede to priority examination for many of them.

On a alternative hand, conventionally, a Regulatory Agencies, together with a FDA, have been not thankful to cruise improved efficiency over existent drug as a pattern for approval; rather, they need customarily a investiture of efficiency as great as reserve of a code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new drug over a placebo.

How great have been they?

Notwithstanding such perceptions, historically, many “me-too” drug have valid to be extremely improved than their strange counterparts. Examples have been a array of generations of beta-blockers, which came up after a strange drug Propanalol was detected by ICI, with many of them carrying merits in conditions of improved efficacy, cardio-selectivity as great as safety. Ranitidine, a primary follow-up drug after a key of a primary H-2 receptor antagonist, Cimetidine, was followed by Famotidine as great as in any box these “me-too” drug had critical merits over a strange drug.

Apart from a vital code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new thing in a growth of orally active beta lactam antibiotics of a Penicillin as great as Cephalosporin class, inside of a same verbal derivatives, there have been substantial improvements brought about by shift in a side bondage incorporated by precipitation of specific agents with 6-APA, 7-ADCA as great as 7-ACA. A total code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new operation of broad-spectrum antibiotics of these constructional classes could to illustrate be developed. In any of a vital classes of antibiotics, personal according to a mechanisms of their action, namely predicament of dungeon wall singularity (Beta Lactams, Vancomycin), predicament of bacterial protein singularity (Erythromycin, Tetracycline, Streptomycin), inhibitors of DNA or RNA riposte (Quinolones, Rifamycins), predicament of Folate Coenzyme biosynthesis (Sulfa drugs, Trimethoprim), there have been multiform “me-too” drug marketed.

An critical code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new e.g. to uncover which ‘me-too” drug need to be grown is a box of a verbal hypoglycemic drug Troglitazone, authorized as an anti-diabetic drug in 1997. The drug was cold from a marketplace following reports of unsuitable hepato-toxicity. The follow-up “me-too” drugs, Rosiglitazone as great as Pioglitazone have been many reduction poisonous as great as have been currently during large used. If these drug were not developed, a withdrawal of Troglitazone would have left a vital healing opening in anti-diabetic therapy.

“Me-Too” drugs: Strategies for New Drug Research for Indian Companies

Breakthrough innovations in curative industry, of code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new drugs, such as a primary beta blocker, a primary NSAID, a primary of any difficulty of Antibiotics, Calcium Channel blockers, ACE inhibitors, Sulfonyl Ureas, Biguanides, Insulin, Glitazones, Glinides, Tricyclic Anti Depressants,major as great as teenager Traquillisers, Selective Serotonin Receptor inhibitors, H-1 as great as H-2 Receptor antagonists, Proton Pump inhibitors etc have been comparatively singular as great as even nonetheless a couple of of a strange drug underneath these classes have been still unequivocally many in use, they have been superceded in many cases, by after epoch products, many of them “me-too”. The newer drug have been detected both by incremental innovations upon a strange drug as great as by code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new research.

Generally a strange find leads to hectic wake up both inside of a dignitary association as great as in Competitors’ laboratories, to rise improved products in a same healing category. The necessary premonition for blurb success, however, is which a newly detected molecules should encounter a smallest standards of patentability. For e.g. inside of 3 years of a find of a rarely successful Sildinafil Citrate (Viagra), 3 some-more code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new versions for a same indications have been law as great as developed5.

Me-too drug additionally yield healing advantage6. For a putting in service physicians, there’s a great of determined drug MoA with a “me-too” medication, joined with clinical studies which – hopefully – uncover patient-centered benefits such as improved inauspicious events profiles, reduction visit dosing, reduction troublesome intensity for drug/drug interactions, as great as so forth. A “me-too” drug is a helluva lot simpler to soak up in have make use of of than a all novel medication7.

“Me-Too” drugs: The dark dynamics

The many usual critique of drug growth centers upon a supposed “me-too” drug which occupy a same biological resource as colonize brands. This involves a lot some-more than such high-profile targets as a anti-ulcer drug Nexium. We should be meditative about antidepressants, cholesterol-reducing drugs, diabetes treatments, anti-psychotics, as great as alternative healing categories which have seen both blockbuster sales as great as fast innovation. There is utterly a bit of justification which follow-on drug do a lot of patients a lot of good. The newer statins, for example, mostly out-perform a comparison ones in clinical trials where a endpoints have been a series of heart attacks as great as deaths prevented.

Me-too drug have been additionally a absolute apparatus for slicing illness caring costs. We should be blissful which a investigate courtesy does not aim customarily code brand code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new biological mechanisms. That would be a unequivocally costly commercial operation indication indeed. Fortunately, a courtesy additionally functions upon extrinsic improvements, exploiting opportunities to have drug caring improved as great as infrequently opening a doorway to unequivocally in advance improvements which occur to distortion some-more or reduction next-door, scientifically speaking. In a meantime, we get price foe as a by-product. Me-too’s roughly regularly undercut a prices of a colonize drugs.

Another partial of a me-too story gets roughly utterly abandoned even nonetheless it is unusual important. For me-too manufacturers, some-more advanced a scholarship is a approach to benefit a rival advantage. The classical e.g. is a statin difficulty of cholesterol drugs. Research upon a single of a follow-on drug (Pravachol) demonstrated for a primary time which regulating a statin to revoke cholesterol would essentially hinder deaths from heart attacks, something which had formerly been insincere nonetheless proof. Additional trials for multiform statins, together with Lipitor, a challenging challenger to Zocor as great as Pravachol, have demonstrated which serum cholesterol is distant some-more critical than roughly any a single suspicion (for preventing strokes, for example).

There have been lots of alternative stories about a benefits of code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new investigate from me-too drugs, nonetheless they have been partial of a incomparable story: code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new uses for aged drugs. The interpretation display a slack in code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new drug approvals bar necessary information: discoveries of code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new uses for aged drugs. This kind of find has spin so usual which it amounts to a “new-use” revolution. One of a systematic ironies of a code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new epoch of curative investigate is which as drug spin some-more firmly targeted upon biological mechanisms, their uses essentially spin some-more diverse. This is since a physique typically uses specific mechanisms over as great as over again, infrequently in what crop up to be utterly separate ways.

Consider a SSRI antidepressants. A code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new Science essay upon a opposite as great as astonishing applications of drug which fiddle with serotonin reuptake which is what a SSRIs do resolved which a unequivocally tenure “antidepressant” is dubious since there is no systematic reason to cruise of this drug as being customarily for depression. Fighting basin customarily happened to be a primary unequivocally utilitarian condition which was explored for this unequivocally engaging difficulty of drugs.

Another e.g. is a Cox-2 inhibitors identical to Celebrex (and Vioxx, which is critical in this story as great as might lapse to a marketplace partly for this reason). These were invented to soothe arthritis pain. But a Cox-2 containing alkali substance turns out to be critical for lots of things together with cancer as great as Alzheimer’s. Clinical trials to feat these leads have been underway for years. Celebrex has already been authorized for shortening a risk of colorectal cancer, as great as Vioxx has additionally completed earnest results. Of course, a large headlines not long ago has been which these drug might means heart attacks. But even here, me-too economics is of leading importance. The normal NSAIDS (non-steroidal anti-inflammatory drugs) identical to Alleve as great as Advil might have a same heart conflict risks. The intensity risk has been there for decades, nonetheless customarily a code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new drugs-the Cox-2s-have been put by large-scale long-term clinical trials since those have been a customarily ones still underneath patent. This is an e.g. of how me-too drug growth adds importantly to a investigate base. Thanks to a me-too’s, we have been guidance about NSAIDs, heart attacks, cancer as great as substantially many more.

Also dominated by code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new uses have been a new-targeted cancer drugs, which conflict such specific biological mechanisms which they equivocate murdering each fast-growing dungeon in steer (as normal chemotherapy tends to do).

The implications have been clear. The annual equate of code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new drug approvals will customarily uncover a parasite when a code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new cancer drug or a code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new statin gets a unequivocally primary approval. But a code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new have have make use of of of for an aged drug can be as essential as an wholly code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new drug, or even some-more essential when we cruise which we know some-more about a reserve form of aged drug as great as a single drug will infrequently do a work of dual (preventing both heart attacks as great as strokes, for example)8.

Me-too products can infrequently have critical advantages upon tolerability or dosing. It could assistance emanate some-more foe as great as revoke a price. If we have 5 me-toos, presumably a sixth is something which is a small better. That is for a skeleton to confirm upon interest of their patients. And even if it has a same resource of action, some-more foe could assistance expostulate down a price of a complete class. That’s an critical influence, with potentially an alleviation in illness from larger access.

How bad have been they?

Even nonetheless a vital complaint of antibiotic therapy, namely drug insurgency cannot be addressed by a growth of “me-too” drugs, due to a inclination of a same difficulty to rise cranky resistance; in many cases, a code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new semi-synthetic derivatives had graphic advantages over a progressing ones. Thus, for example, a primary epoch Cephalosporins have been utilitarian for gram-positive infections, whilst a second-generation drug cover a broader spectrum together with gram-negative organisms. The third epoch drug yield insurgency opposite a beta lactamase enzyme, as great as behaving opposite a small of a many bullheaded infections, such as those caused by Pseudomonas as great as Klebsiella strains.

Even whilst a curative courtesy turns out family groups of me-too drug for comparatively amiable conditions in abundant people, it pays roughly no courtesy to critical diseases, such as malaria, inspiring bankrupt people. It additionally gives reduced shrift to reduction essential drugs, so there right away have been shortages of a small vaccines as great as life-saving drugs9.

The large complaint with me-too drug is which they have been chemically unequivocally matching to alternative drug already available, nonetheless they have been marketed as if they were critical code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new breakthroughs, with unequivocally tall prices. Many new, costly me-too drug have been not indispensably improved than comparison as great as reduction costly drugs. Most of a time they have been compared with placebos as great as not comparison drug comparisons.

“Me-too” drug have been obliged for 80% of increasing spending in code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new years, as great as upon normal they have been 4 times some-more costly than a comparable, comparison alternatives10. By Patented Medicines Pricing Review Board’s (PMPRB) definitions, during a time of their key “me-too” drug were judged to yield moderate, small or no alleviation – in conditions of efficacy as great as reserve – compared to comparison alternatives. However, upon average, “me-too” drug price about 2.5 times as many per medication as allied comparison drugs. The subject is either a viewed or genuine differences clear a increasing costs. New drug do have a purpose in a small situations as great as for a small patients. However, it creates clarity to have have make use of of of a comparison similarly in effect drug during your convenience possible11.

Changing FDA manners to daunt me-too drug approvals would have R&D distant some-more expensive, would daunt foe as great as thus lift healthcare costs, as great as would hinder a call of code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new investigate which has revolutionized a systematic bargain of a healing categories where foe has been many intense.

Conclusion

New drug have been not compulsory to urge upon aged ones, as great as there’s customarily no approach to know either they do. Although a FDA contingency exam drug prior to they have been marketed, they don’t need to be compared with matching drug already upon a market. The FDA customarily requires they be pretty protected as great as improved than nothing-a low customary indeed. This loophole in FDA regulations opens a doorway for an total series of me-too drugs, which have been simpler to rise than innovative drugs.

Given everything, it should come as no warn which these some-more costly “me-too” drug price a healing courtesy money. The superiority of a me-too’s unequivocally says an horrible lot about a miss of creation inside of a curative industry. If we demeanour during a code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new drug marketed over a final 6 years, 78 percent weren’t even code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new containing alkali compounds. They were customarily code brand code brand code brand code brand code brand code brand code brand code brand code brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand brand new combinations or opposite formulations of aged drugs. And 68 percent were personal by a F.D.A. as doubtful to be improvements over drug already upon pharmacy shelves.

At a same time, there have been shortages of a small critical drug which a curative companies aren’t many meddlesome in creation since they have been not as essential as a me-too’s. But a companies do not have to spin out indispensable drugs, if they have been not lucrative. And they don’t.

References

1. http://www.medterms.com/script/main/art.asp?articlekey=33748

2. http://www.motherjones.com/news/qa/2004/09/09_401.html

3. http://polyscience.org/2005/09/me-too-drugs

4. http://www.shvoong.com/books/465475-me-too-drugs

5. http://www.pharmabiz.com/article/detnews.asp?SecArch=&articleid=14604&sectionid=46

6. http://direct.bl.uk/bld/PlaceOrder.do?UIN=162532605&ETOC=RN&from=searchengine

7. http://www.archivum.info/sci.med/2005-09/msg00257.html

8. http://www.aei.org/publications/filter.all,pubID.27443/pub_detail.asp

9. http://blogs.wsj.com/health/2007/05/17/in-praise-of-me-too-drugs

10. http://www.chepa.org/KnowledgeExchange/LabelleLectureship/tabid/84/Default.aspx

11. http://www.ti.ubc.ca/pages/letter59.html

Share this Post[?]